Top

The Patient - Patient-Centered Outcomes Research

Published in:

01-08-2017 | Original Research Article

EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation

Authors: Carlos K. H. Wong, Brian H. H. Lang, Hill M. S. Yu, Cindy L. K. Lam

Published in: The Patient - Patient-Centered Outcomes Research | Issue 4/2017

Abstract

Purpose

The aim of this study was to examine the acceptability, validity, and reliability of the EuroQoL Five-Dimension Five-Level (EQ-5D-5L) and Short-Form Six-Dimension (SF-6D) health utility measures in patients with symptomatic benign thyroid nodules.

Methods

Data from a randomized controlled trial (ClinicalTrials.gov identifier: NCT02398721) of 294 patients with symptomatic benign thyroid nodules were utilized for this psychometric evaluation of health-related quality of life (HR-QOL) measurement. Three HR-QOL questionnaires—the generic 12-item Short Form Health Survey (SF-12v2), EQ-5D-5L, and SF-6D—were interviewer-administered at baseline and 2 weeks afterwards. Responses to SF-6D were transformed to SF-6D utility scores using a Hong Kong population scoring algorithm derived by standard gamble, whereas responses to EQ-5D-5L were mapped onto EQ-5D-3L response via interim mapping algorithms and then converted to EQ-5D-5L utility scores using a Chinese-specific value set. Construct validity was determined by evaluating Spearman correlation between SF-12v2 scores and utility scores. Two-week test–retest reliability was assessed using intra-class correlation coefficient.

Results

No significant (>15%) floor and ceiling effects were observed for SF-6D utility scores. The SF-6D utility scores had a moderate Spearman rank correlation with the SF-12v2 domain score providing evidence for adequate construct validity. The SF-6D utility scores showed good test–retest reliability (0.794; range 0.696–0.860). Better reliability was observed in SF-6D utility scores than in EQ-5D-5L utility scores.

Conclusions

While the EQ-5D-5L instrument was less reproducible, the SF-6D instrument appeared to be an applicable, valid, and reliable measure in assessing the HR-QOL of Chinese patients with symptomatic benign thyroid nodules. The impact of utility score selection on the effectiveness and cost effectiveness of clinical interventions targeted to these patients needs further exploration.

Clinical trial number and registry

NCT02398721, ClinicalTrials.gov.

Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedüs L, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules—2016 Update. Endocr Pract. 2016;22(5):622–39. doi:10.4158/EP161208.GL.CrossRefPubMed

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1–133. doi:10.1089/thy.2015.0020.CrossRefPubMedPubMedCentral

Che Y, Jin S, Shi C, Wang L, Zhang X, Li Y, et al. Treatment of benign thyroid nodules: comparison of surgery with radiofrequency ablation. Am J Neuroradiol. 2015;36(7):1321–5. doi:10.3174/ajnr.A4276.CrossRefPubMedPubMedCentral

Valcavi R, Tsamatropoulos P. Health-related quality of life after percutaneous radiofrequency ablation of cold, solid, benign thyroid nodules: a 2-year follow-up study in 40 patients. Endocr Pract. 2015;21(8):887–96. doi:10.4158/ep15676.or.CrossRefPubMed

Spiezia S, Garberoglio R, Milone F, Ramundo V, Caiazzo C, Assanti AP, et al. Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation. Thyroid. 2009;19(3):219–25. doi:10.1089/thy.2008.0202.CrossRefPubMed

Yue W-W, Li X-L, Xu H-X, Lu F, Sun L-P, Guo L-H, et al. Quality of life and cost-effectiveness of radiofrequency ablation versus open surgery for benign thyroid nodules: a retrospective cohort study. Sci Rep. 2016;6:37838. doi:10.1038/srep37838.CrossRefPubMedPubMedCentral

Pan C-W, Sun H-P, Zhou H-J, Ma Q, Xu Y, Luo N, et al. Valuing health-related quality of life in type 2 diabetes patients in China. Med Decis Mak. 2016;36(2):234–41. doi:10.1177/0272989x15606903.CrossRef

Pan C-W, Sun H-P, Wang X, Ma Q, Xu Y, Luo N, et al. The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients. Qual Life Res. 2015;24(7):1767–74. doi:10.1007/s11136-014-0902-6.CrossRefPubMed

Cheung PHW, Wong CKH, Samartzis D, Luk KKD, Lam CLK, Cheung KMC, et al. Psychometric validation of the EuroQoL 5-Dimension 5-Level (EQ-5D-5L) in Chinese patients with adolescent idiopathic scoliosis. Scoliosis Spinal Disord. 2016;11(1):19. doi:10.1186/s13013-016-0083-x.CrossRefPubMedPubMedCentral

10.

van Hout B, Janssen MF, Feng Y-S, Kohlmann T, Busschbach J, Golicki D, et al. Interim Scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708–15. doi:10.1016/j.jval.2012.02.008.CrossRefPubMed

11.

Liu GG, Wu H, Li M, Gao C, Luo N. Chinese time trade-off values for EQ-5D health states. Value Health. 2014;17(5):597–604. doi:10.1016/j.jval.2014.05.007.CrossRefPubMed

12.

Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42(9):851–9.CrossRefPubMed

13.

Wong CKH, Lam ETP, Lam CLK. Comparison of direct-measured and derived short form six dimensions (SF-6D) health preference values among chronic hepatitis B patients. Qual Life Res. 2013;22(10):2973–81. doi:10.1007/s11136-013-0403-z.CrossRefPubMed

14.

Lam CLK, Brazier J, McGhee SM. Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population. Value Health. 2008;11(2):295–303. doi:10.1111/j.1524-4733.2007.00233.x.CrossRefPubMed

15.

McGhee SM, Brazier J, Lam CL, Wong LC, Chau J, Cheung A, et al. Quality-adjusted life years: population-specific measurement of the quality component. Hong Kong Med J. 2011;17(Suppl 6):17–21.PubMed

16.

Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis. 1987;40(2):171–8. doi:10.1016/0021-9681(87)90069-5.CrossRefPubMed

17.

Guyatt GH, Deyo RA, Charlson M, Levine MN, Mitchell A. Responsiveness and validity in health status measurement: a clarification. J Clin Epidemiol. 1989;42(5):403–8. doi:10.1016/0895-4356(89)90128-5.CrossRefPubMed

18.

Fitzpatrick R, Davey C, Buxton M, Jones D. Evaluating patient-based outcome measures for use in clinical trials: a review. Health Technol Assess. 1998;2(14):1–74. doi:10.3310/hta2140.CrossRefPubMed

19.

Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull. 1968;70(4):213–20.CrossRefPubMed

20.

Terwee CB, Bot SDM, de Boer MR, van der Windt DAWM, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42. doi:10.1016/j.jclinepi.2006.03.012.CrossRefPubMed

21.

Marx RG, Menezes A, Horovitz L, Jones EC, Warren RF. A comparison of two time intervals for test-retest reliability of health status instruments. J Clin Epidemiol. 2003;56(8):730–5. doi:10.1016/S0895-4356(03)00084-2.CrossRefPubMed

22.

Wong CKH, Lang BHH, Lam CLK. A systematic review of quality of thyroid-specific health-related quality-of-life instruments recommends ThyPRO for patients with benign thyroid diseases. J Clin Epidemiol. 2016;78:63–72. doi:10.1016/j.jclinepi.2016.03.006.CrossRefPubMed

23.

Watt T, Barbesino G, Bjorner JB, Bonnema SJ, Bukvic B, Drummond R, et al. Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO. Qual Life Res. 2015;24(3):769–80. doi:10.1007/s11136-014-0798-1.CrossRefPubMed

24.

Lam CLK, Tse EYY, Gandek B. Is the standard SF-12 health survey valid and equivalent for a Chinese population? Qual Life Res. 2005;14(2):539–47.CrossRefPubMed

Title: EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation
Authors: Carlos K. H. Wong
Brian H. H. Lang
Hill M. S. Yu
Cindy L. K. Lam
Publication date: 01-08-2017
Publisher: Springer International Publishing
Published in: The Patient - Patient-Centered Outcomes Research / Issue 4/2017
Print ISSN: 1178-1653
Electronic ISSN: 1178-1661
DOI: https://doi.org/10.1007/s40271-017-0220-5

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Clinical trial number and registry

Please log in to get access to this content

Other articles of this Issue 4/2017

Art and Science of Instrument Development for Stated-Preference Methods

Giving Patients a Meaningful Voice in European Health Technology Assessments: The Role of Health Preference Research

Development of a Report Card for Identifying Local Sublingual Immunotherapy Events in Clinical Trials

Preparing Parents to Make An Informed Choice About Antibiotic Use for Common Acute Respiratory Infections in Children: A Randomised Trial of Brief Decision Aids in a Hypothetical Scenario

Preferences for Health Interventions: Improving Uptake, Adherence, and Efficiency

Assessment of Individual Patient Preferences to Inform Clinical Practice

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials